Press Releases
Recro Pharma Announces Five-Year Manufacturing and Supply Agreement Between Novartis and Recro Gainesville
Recro Pharma Amends Athyrium Credit Facility
Recro Pharma Amends IV Meloxicam License Agreement with Alkermes
Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam’s Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology
Recro Pharma Announces Publication of Phase II IV Meloxicam Abdominal Hysterectomy Data in Anesthesia & Analgesia
Recro Pharma to Participate in Upcoming Investor Conferences
Recro Pharma Reports Third Quarter 2018 Financial Results Raising Guidance for CDMO business for 2018
Recro Pharma to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
Recro Pharma Announces PDUFA Date for IV Meloxicam
